Lionel Collet, president of the High Authority of Health, denounces pressure of “never before seen proportions” from the pharmaceutical industry

Attempts to influence certain pharmaceutical companies with a view to obtaining reimbursement for their treatments from Health Insurance are increasing with the institution, “with a very clear acceleration since the end of 2025”, its leader reports to “Le Monde”.